Biophytis Stock Total Asset
Biophytis fundamentals help investors to digest information that contributes to Biophytis' financial success or failures. It also enables traders to predict the movement of Biophytis Stock. The fundamental analysis module provides a way to measure Biophytis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biophytis stock.
Biophytis |
Biophytis Company Total Asset Analysis
Biophytis' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Biophytis Total Asset | 11.94 M |
Most of Biophytis' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biophytis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Biophytis has a Total Asset of 11.94 M. This is 99.84% lower than that of the Biotechnology sector and 99.4% lower than that of the Health Care industry. The total asset for all United States stocks is 99.96% higher than that of the company.
Biophytis Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biophytis' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics of similar companies.Biophytis is currently under evaluation in total asset category among its peers.
Biophytis Fundamentals
| Return On Equity | -12.44 | |||
| Return On Asset | -0.53 | |||
| Current Valuation | 9.73 B | |||
| Shares Outstanding | 286.5 K | |||
| Shares Owned By Institutions | 0.04 % | |||
| Number Of Shares Shorted | 368.95 K | |||
| Price To Book | 2.26 X | |||
| EBITDA | (15.09 M) | |||
| Net Income | (17.03 M) | |||
| Cash And Equivalents | 23.93 M | |||
| Cash Per Share | 1.71 X | |||
| Total Debt | 8.27 M | |||
| Debt To Equity | 3.27 % | |||
| Current Ratio | 1.37 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (13.33 M) | |||
| Short Ratio | 0.41 X | |||
| Earnings Per Share | (128.39) X | |||
| Target Price | 6000.0 | |||
| Number Of Employees | 22 | |||
| Beta | 1.05 | |||
| Market Capitalization | 2.61 M | |||
| Total Asset | 11.94 M | |||
| Retained Earnings | (19.38 M) | |||
| Working Capital | (3.52 M) | |||
| Net Asset | 11.94 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |